Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

NCT01967940 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV
HIV Infections
Acquired Immunodeficiency Syndrome

Interventions

DRUG: TAF
DRUG: Placebo
DRUG: E/C/F/TAF
DRUG: Current failing ARV regimen
DRUG: ATV

Sponsor

Gilead Sciences